Critical Limb Ischemia Treatment Market, By Drugs, By Route of administration, By End User, By Geography

Description

The global critical limb ischemia treatment market is estimated to be valued at USD 5.10 Bn in 2024 and is expected to reach USD 9.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2024:	US$ 5.10 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2024 to 2031 CAGR:	8.60%	2031 Value Projection:	US$ 9.11 Bn

Figure. Critical Limb Ischemia Treatment Market Share (%), By Region 2024

Critical Limb Ischemia Treatment Market - IMG1

Global critical limb ischemia treatment market refers to the medical condition where the blood circulation to extremities like legs is severely reduced. This is a serious condition that can lead to amputation if left untreated. The condition arises due to the accumulation of fatty substances in arteries leading to atherosclerosis. The limited blood flow leads to severe pain and sores on extremities which do not heal. The global critical limb ischemia treatment market is poised to grow significantly in the coming years due to increasing geriatric population, rising cases of peripheral artery diseases, and growing awareness regarding available treatment options.

Market Dynamics:

The global critical limb ischemia treatment market is driven by the rising prevalence of diabetes and growing geriatric population globally which are major risk factors for CLI. Additionally, increasing research funding for the development of advanced treatment devices and drugs is also boosting the market growth. However, high cost of angioplasty and vascular surgeries hampers patient's accessibility to treatment. Growing awareness about CLI and availability of reimbursement coverage in developed nations provides lucrative opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global critical limb ischemia treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global critical limb ischemia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Boston Scientific, Cardinal Health, Terumo, Abbott Laboratories, etc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global critical limb ischemia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global critical limb ischemia treatment market

Detailed Segmentation-

By Drugs
- Antihypertensive Agents
- Antiplatelet Drugs
- Antithrombotic Agents
- Lipid-lowering Agents
- Others
By Route of administration
- Oral
- Parentral
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgery Centers
- Nursing Homes
- Others (Rehabilitation Centers, etc.)
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Cook Medical Inc.
- Cardiovascular Systems, Inc.
- Philips Healthcare
- Braun Melsungen AG
- Terumo Corporation
- Biotronik SE & Co. KG
- Cordis Corporation
- Smith & Nephew plc
- Stryker Corporation
- AngioDynamics, Inc.
- GE Healthcare
- Sanofi S.A.
- AstraZeneca plc
- Bristol-Myers Squibb Company

Product Code: CMI7115

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drugs
- Market Snapshot, By Route of Administration
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Critical Limb Ischemia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Critical Limb Ischemia Treatment Market, By Drugs, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Antihypertensive Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antiplatelet Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antithrombotic Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Lipid-lowering Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Critical Limb Ischemia Treatment Market, By Route of Administration 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parentral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Critical Limb Ischemia Treatment Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ambulatory Surgery Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Nursing Homes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Critical Limb Ischemia Treatment Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Advanced Brain Monitoring, Inc.
  - Company Highlights
  - Drugs Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Medtronic plc
  - Boston Scienti Company Highlights
  - Drugs Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- fic Corporation
  - Company Highlights
  - Drugs Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbott Laboratories
  - Company Highlights
  - Drugs Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cook Medical Inc.
  - Company Highlights
  - Drugs Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cardiovascular Systems, Inc.
  - Company Highlights
  - Drugs Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Philips Healthcare
- B. Braun Melsungen AG
- Terumo Corporation
- Biotronik SE & Co. KG
- Cordis Corporation
- Smith & Nephew plc
- Stryker Corporation
- AngioDynamics, Inc.
- GE Healthcare
- Sanofi S.A.
- AstraZeneca plc
- Bristol-Myers Squibb Company

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. Reference and Research Methodology

References
Research Methodology
About us and Sales Contact